Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AVE Science & Technology CoSHSE:688067 +3.03%79 EV-to-FCF is 30.56 as of Jul. 29, 2026, which is 43% below its 10-year median of 53.54. GuruFocus rates SHSE:688067 with a GF Score™ of 79/100 and a GF Value™ of ¥24.21 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 417 Medical Devices & Instruments companies, AVE Science & Technology Co ranks worse than 63.31% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, AVE Science & Technology Co's Enterprise Value is ¥1,106.5 Mil.
AVE Science & Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥36.2 Mil. Therefore, AVE Science & Technology Co's EV-to-FCF for today is 30.56.
The historical rank and industry rank for AVE Science & Technology Co's EV-to-FCF or its related term are showing as below:
SHSE:688067'
s EV-to-FCF Range Over the Past 10 Years
Min: 24.74 Med: 53.54 Max: 306.6
Current: 31.91
During the past 13 years, the highest EV-to-FCF of AVE Science & Technology Co was 306.60. The lowest was 24.74. And the median was 53.54.
SHSE:688067's EV-to-FCF is ranked worse than 63.31% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 23.13
vs SHSE:688067: 31.91
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
AVE Science & Technology Co (SHSE:688067) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
AVE Science & Technology Co's PE Ratio (TTM) for today is calculated as:
AVE Science & Technology Co's share price for today is ¥19.36.
AVE Science & Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.450.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
AVE Science & Technology Co EV-to-FCF Related Terms
AVE Science & Technology Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688067 vs ISRG, BDX, MDLN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, AVE Science & Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AVE Science & Technology Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AVE Science & Technology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where AVE Science & Technology Co's EV-to-FCF falls into.
AVE Science & Technology Co's current Enterprise Value is ¥1,106.5 Mil.
AVE Science & Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥36.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVE Science & Technology Co (SHSE:688067) has a EV-to-FCF of 30.56 as of Jul. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on AVE Science & Technology Co and its competitors. This is 43% below median its historical median of 53.54. Over the past decade, AVE Science & Technology Co's EV-to-FCF has ranged from 24.74 to 306.60. According to the industry distribution chart, AVE Science & Technology Co ranks #264 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 63.3%.
Is AVE Science & Technology Co's EV-to-FCF too high?
AVE Science & Technology Co's current EV-to-FCF of 30.56 is 43% below median its 10-year median of 53.54. Over the past 10 years, this metric has ranged from a low of 24.74 to a high of 306.60. The Medical Devices & Instruments industry median EV-to-FCF is 23.13. AVE Science & Technology Co's value of 30.56 is 32.1% above this industry median. Based on the distribution chart, AVE Science & Technology Co ranks #264 out of 417 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, AVE Science & Technology Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AVE Science & Technology Co's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, AVE Science & Technology Co ranks #264 out of 417 companies for EV-to-FCF. This places AVE Science & Technology Co in the lower half of its industry. The industry median EV-to-FCF is 23.13. AVE Science & Technology Co's value of 30.56 is 32.1% above this benchmark. Historically, AVE Science & Technology Co's own EV-to-FCF has ranged from 24.74 to 306.60 over the past decade. While the company's 10-year median is 53.54 vs. the industry median of 23.13, AVE Science & Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.13, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AVE Science & Technology Co's current EV-to-FCF of 30.56 is 32.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on AVE Science & Technology Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AVE Science & Technology Co's current EV-to-FCF is 30.56, which is 43% below median its own 10-year median of 53.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVE Science & Technology Co stock overvalued right now?
Based on GuruFocus' analysis, AVE Science & Technology Co (SHSE:688067) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.21, compared to a current price of ¥19.36 — trading 20% below its estimated fair value. The current EV-to-FCF is 30.56, which is 43% below median its 10-year median of 53.54 and 32.1% above the Medical Devices & Instruments industry median of 23.13. AVE Science & Technology Co's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For AVE Science & Technology Co (SHSE:688067), the current EV-to-FCF is 30.56 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AVE Science & Technology Co (SHSE:688067) Overvalued in 2026?
Based on GuruFocus' analysis, AVE Science & Technology Co stock appears to be undervalued.
The current stock price of ¥19.36 is trading 20% below its estimated GF Value™ of ¥24.21.
GuruFocus considers AVE Science & Technology Co to be Modestly Undervalued.
Key valuation signals for SHSE:688067:
EV-to-FCF: 30.56 (43% below median its 10-year median of 53.54)
GF Value™: ¥24.21 vs. price of ¥19.36 (20% below fair value)
Industry Position: 32.1% above the Medical Devices & Instruments median (#264 of 417)
No single metric tells the full story. See the SHSE:688067 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AVE Science & Technology Co Ltd is engaged in the research and development, production, sales and service of medical clinical laboratory analysis instruments and supporting in vitro diagnostic reagents and medical consumables.
79GF Score
Get the complete analysis for SHSE:688067
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688067 has been successfully added to your 
